Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	MYH4 MYH7 ABCA2 MYH13 CENPE DYNC2H1 ABCC9 CHD2 CHD1L MSH3 MSH4 HELQ KIF24 ATP8B2 DNAH14 ABCB1 UBA6 ATP1A2	9.52e-07	614	151	18	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH4 MYH7 MYH13 CENPE DYNC2H1 KIF24 DNAH14	3.22e-05	118	151	7	GO:0003774
GeneOntologyMolecularFunction	ceramide floppase activity	ABCA2 ABCB1	1.70e-04	3	151	2	GO:0099038
GeneOntologyMolecularFunction	floppase activity	ABCA2 ATP8B2 ABCB1	2.21e-04	16	151	3	GO:0140328
GeneOntologyMolecularFunction	sphingolipid floppase activity	ABCA2 ABCB1	3.37e-04	4	151	2	GO:0046623
GeneOntologyMolecularFunction	SUMO binding	HERC2 USPL1 PML	3.76e-04	19	151	3	GO:0032183
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYH4 MYH7 ABCA2 DYNC2H1 ABCC9 CHD2 CHD1L HELQ ATP8B2 ABCB1 ATP1A2	5.42e-04	441	151	11	GO:0016887
MousePheno	abnormal internal female genitalia morphology	FMO3 ATR FAT3 WNT9B PGBD1 CHD2 MSH4 HELQ FANCD2 BMPR1B PRDM8 PTP4A3 SGPL1 DUSP16 ASPM AHR GAB3 SPATA22 HERC2 DOP1A	1.20e-05	757	125	20	MP:0009209
MousePheno	abnormal female genitalia morphology	FMO3 ATR FAT3 WNT9B PGBD1 CHD2 MSH4 HELQ FANCD2 BMPR1B PRDM8 PTP4A3 SGPL1 DUSP16 ASPM AHR GAB3 SPATA22 HERC2 DOP1A	1.35e-05	763	125	20	MP:0009208
MousePheno	abnormal female reproductive system morphology	FMO3 ATR FAT3 WNT9B PGBD1 CHD2 MSH4 HELQ FANCD2 BMPR1B PRDM8 PTP4A3 SGPL1 DUSP16 ASPM AHR GAB3 SPATA22 HERC2 DOP1A	1.43e-05	766	125	20	MP:0001119
MousePheno	abnormal ovary size	FMO3 ATR FAT3 MSH4 HELQ FANCD2 SGPL1 ASPM AHR SPATA22	3.78e-05	228	125	10	MP:0004853
Domain	Myosin-like_IQ_dom	MYH4 MYH7 MYH13 ASPM	1.37e-05	19	149	4	IPR027401
Domain	-	MYH4 MYH7 MYH13 ASPM	1.37e-05	19	149	4	4.10.270.10
Domain	DHHA2	PRUNE2 PRUNE1	6.32e-05	2	149	2	IPR004097
Domain	DHHA2	PRUNE2 PRUNE1	6.32e-05	2	149	2	PF02833
Domain	DHHA2	PRUNE2 PRUNE1	6.32e-05	2	149	2	SM01131
Domain	-	MSH3 MSH4	1.89e-04	3	149	2	3.30.420.110
Domain	-	RASA4 RASA4B	1.89e-04	3	149	2	4.10.1130.10
Domain	Myosin_N	MYH4 MYH7 MYH13	2.11e-04	15	149	3	PF02736
Domain	Myosin_N	MYH4 MYH7 MYH13	2.11e-04	15	149	3	IPR004009
Domain	Myosin_tail_1	MYH4 MYH7 MYH13	3.72e-04	18	149	3	PF01576
Domain	Myosin_tail	MYH4 MYH7 MYH13	3.72e-04	18	149	3	IPR002928
Domain	DNA_mmatch_repair_MutS_con_dom	MSH3 MSH4	3.75e-04	4	149	2	IPR007860
Domain	MutS_II	MSH3 MSH4	3.75e-04	4	149	2	PF05188
Domain	P-loop_NTPase	MYH4 MYH7 ABCA2 MYH13 CENPE DYNC2H1 ABCC9 CHD2 CHD1L MSH3 MSH4 HELQ KIF24 DNAH14 ABCB1 ASPM CNP	4.37e-04	848	149	17	IPR027417
Domain	IQ	MYH4 MYH7 MYH13 UBE3B ASPM	4.75e-04	81	149	5	SM00015
Domain	PolyA	PABPC4 PABPC1	6.22e-04	5	149	2	SM00517
Domain	MUTSd	MSH3 MSH4	6.22e-04	5	149	2	SM00533
Domain	MUTSac	MSH3 MSH4	6.22e-04	5	149	2	SM00534
Domain	MutS_V	MSH3 MSH4	6.22e-04	5	149	2	PF00488
Domain	-	PABPC4 PABPC1	6.22e-04	5	149	2	1.10.1900.10
Domain	PABP	PABPC4 PABPC1	6.22e-04	5	149	2	PF00658
Domain	DNA_mismatch_repair_MutS_clamp	MSH3 MSH4	6.22e-04	5	149	2	IPR007861
Domain	PABP_1234	PABPC4 PABPC1	6.22e-04	5	149	2	IPR006515
Domain	DNA_MISMATCH_REPAIR_2	MSH3 MSH4	6.22e-04	5	149	2	PS00486
Domain	MutS_IV	MSH3 MSH4	6.22e-04	5	149	2	PF05190
Domain	MutS_III	MSH3 MSH4	6.22e-04	5	149	2	PF05192
Domain	DNA_mismatch_repair_MutS_C	MSH3 MSH4	6.22e-04	5	149	2	IPR000432
Domain	DNA_mismatch_repair_MutS_core	MSH3 MSH4	6.22e-04	5	149	2	IPR007696
Domain	FATC	SMG1 ATR	6.22e-04	5	149	2	PF02260
Domain	PABC	PABPC4 PABPC1	6.22e-04	5	149	2	PS51309
Domain	DUF4371	FAM200A ZMYM6	6.22e-04	5	149	2	IPR025398
Domain	PABP_HYD	PABPC4 PABPC1	6.22e-04	5	149	2	IPR002004
Domain	DUF4371	FAM200A ZMYM6	6.22e-04	5	149	2	PF14291
Domain	PH_dom-like	DOCK9 FRMPD2 ANKS1B PLEKHS1 FGD4 ELMO2 RASA4 GAB3 RASA4B PLCB2 CADPS2	6.30e-04	426	149	11	IPR011993
Domain	IQ_motif_EF-hand-BS	MYH4 MYH7 MYH13 UBE3B ASPM	7.70e-04	90	149	5	IPR000048
Domain	IQ	MYH4 MYH7 MYH13 UBE3B ASPM	8.94e-04	93	149	5	PS50096
Domain	FAT	SMG1 ATR	9.29e-04	6	149	2	PS51189
Domain	FATC	SMG1 ATR	9.29e-04	6	149	2	PS51190
Domain	FAT	ATR TMTC1	9.29e-04	6	149	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR TMTC1	9.29e-04	6	149	2	IPR003151
Domain	FATC_dom	SMG1 ATR	9.29e-04	6	149	2	IPR003152
Domain	PIK_FAT	SMG1 ATR	9.29e-04	6	149	2	IPR014009
Domain	FATC	SMG1 ATR	9.29e-04	6	149	2	SM01343
Domain	-	DOCK9 FRMPD2 ANKS1B PLEKHS1 FGD4 ELMO2 RASA4 GAB3 RASA4B CADPS2	1.19e-03	391	149	10	2.30.29.30
Domain	HECT	UBE3B TRIP12 HERC2	1.26e-03	27	149	3	PF00632
Domain	HECTc	UBE3B TRIP12 HERC2	1.26e-03	27	149	3	SM00119
Domain	HECT_dom	UBE3B TRIP12 HERC2	1.26e-03	27	149	3	IPR000569
Domain	HECT	UBE3B TRIP12 HERC2	1.26e-03	27	149	3	PS50237
Domain	CAMSAP_CH	ASPM CAMSAP2	1.29e-03	7	149	2	PF11971
Domain	CAMSAP_CH	ASPM CAMSAP2	1.29e-03	7	149	2	IPR022613
Domain	PyrdxlP-dep_de-COase	SGPL1 HDC	1.72e-03	8	149	2	IPR002129
Domain	Pyridoxal_deC	SGPL1 HDC	1.72e-03	8	149	2	PF00282
Domain	DDC_GAD_HDC_YDC	SGPL1 HDC	1.72e-03	8	149	2	PS00392
Domain	PH	DOCK9 PLEKHS1 FGD4 ELMO2 RASA4 GAB3 RASA4B CADPS2	1.78e-03	278	149	8	SM00233
Domain	PH_DOMAIN	DOCK9 PLEKHS1 FGD4 ELMO2 RASA4 GAB3 RASA4B CADPS2	1.82e-03	279	149	8	PS50003
Domain	PH_domain	DOCK9 PLEKHS1 FGD4 ELMO2 RASA4 GAB3 RASA4B CADPS2	1.86e-03	280	149	8	IPR001849
Domain	BTK	RASA4 RASA4B	2.19e-03	9	149	2	SM00107
Domain	Znf_Btk_motif	RASA4 RASA4B	2.19e-03	9	149	2	IPR001562
Domain	BTK	RASA4 RASA4B	2.19e-03	9	149	2	PF00779
Domain	ZF_BTK	RASA4 RASA4B	2.19e-03	9	149	2	PS51113
Domain	PH	DOCK9 PLEKHS1 FGD4 RASA4 GAB3 RASA4B CADPS2	2.45e-03	229	149	7	PF00169
Domain	IQ	MYH4 MYH13 UBE3B ASPM	2.50e-03	71	149	4	PF00612
Domain	U2A'_phosphoprotein32A_C	ANP32E NXF1	3.32e-03	11	149	2	IPR003603
Domain	LRRcap	ANP32E NXF1	3.32e-03	11	149	2	SM00446
Domain	Myosin_head_motor_dom	MYH4 MYH7 MYH13	3.42e-03	38	149	3	IPR001609
Domain	MYOSIN_MOTOR	MYH4 MYH7 MYH13	3.42e-03	38	149	3	PS51456
Domain	LAM_G_DOMAIN	FAT3 LAMA3 NRXN3	3.42e-03	38	149	3	PS50025
Domain	Myosin_head	MYH4 MYH7 MYH13	3.42e-03	38	149	3	PF00063
Domain	MYSc	MYH4 MYH7 MYH13	3.42e-03	38	149	3	SM00242
Domain	Laminin_G_2	FAT3 LAMA3 NRXN3	3.96e-03	40	149	3	PF02210
Domain	C2	CPNE8 RASA4 RASA4B PLCB2 CADPS2	4.02e-03	131	149	5	PF00168
Domain	ABC_transporter_CS	ABCA2 ABCC9 ABCB1	4.55e-03	42	149	3	IPR017871
Domain	C2	CPNE8 RASA4 RASA4B PLCB2 CADPS2	4.86e-03	137	149	5	SM00239
Domain	LamG	FAT3 LAMA3 NRXN3	5.19e-03	44	149	3	SM00282
Domain	RasGAP	RASA4 RASA4B	5.40e-03	14	149	2	SM00323
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH14	5.40e-03	14	149	2	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DNAH14	5.40e-03	14	149	2	IPR024743
Domain	MT	DYNC2H1 DNAH14	5.40e-03	14	149	2	PF12777
Domain	AAA_8	DYNC2H1 DNAH14	5.40e-03	14	149	2	PF12780
Domain	RasGAP_CS	RASA4 RASA4B	5.40e-03	14	149	2	IPR023152
Domain	C2	CPNE8 RASA4 RASA4B PLCB2 CADPS2	5.65e-03	142	149	5	PS50004
Domain	ARM-type_fold	SMG1 RELCH ZBTB7C ATR DOCK9 TRIP12 ELMO2 ASPM	5.92e-03	339	149	8	IPR016024
Domain	DHC_fam	DYNC2H1 DNAH14	6.20e-03	15	149	2	IPR026983
Domain	RasGAP	RASA4 RASA4B	6.20e-03	15	149	2	PF00616
Domain	RAS_GTPASE_ACTIV_1	RASA4 RASA4B	6.20e-03	15	149	2	PS00509
Domain	Dynein_heavy	DYNC2H1 DNAH14	6.20e-03	15	149	2	PF03028
Domain	PI3/4_kinase_CS	SMG1 ATR	6.20e-03	15	149	2	IPR018936
Domain	RAS_GTPASE_ACTIV_2	RASA4 RASA4B	6.20e-03	15	149	2	PS50018
Domain	Dynein_heavy_dom	DYNC2H1 DNAH14	6.20e-03	15	149	2	IPR004273
Domain	ABC_tran	ABCA2 ABCC9 ABCB1	6.62e-03	48	149	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCA2 ABCC9 ABCB1	6.62e-03	48	149	3	PS50893
Domain	ABC_TRANSPORTER_1	ABCA2 ABCC9 ABCB1	7.01e-03	49	149	3	PS00211
Domain	-	SMG1 ATR	7.05e-03	16	149	2	1.10.1070.11
Domain	PI3Kc	SMG1 ATR	7.05e-03	16	149	2	SM00146
Domain	-	RASA4 RASA4B	7.05e-03	16	149	2	1.10.506.10
Domain	ABC_transporter-like	ABCA2 ABCC9 ABCB1	7.42e-03	50	149	3	IPR003439
Domain	HEAT_type_2	RELCH ATR	7.95e-03	17	149	2	IPR021133
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SMG1 MYH4 MYH7 MYH13 SYNE1 SIPA1L3 FBF1 PABPC4 ANKS1B SPG11 CHD2 TRIP12 PABPC1 ABCB1 BMPR1B PRDM8 NRXN3 P4HB MTNR1A ASPM SAFB2 MPHOSPH10 ATP1A2 USPL1 CADPS2 CAMSAP2 PCDHGC3 DOP1A	3.60e-11	1442	153	28	35575683
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	ANK3 CENPE SIPA1L3 FBF1 CDH23 CHD1L TRIP12 ARSG LINS1 CLCNKA SGPL1 CADPS2 NXF1	8.49e-09	361	153	13	26167880
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPR ANK3 CENPE SYNE1 SIPA1L3 ANKS1B GRM1 PABPC1 NEK9 STOX2 ANAPC1 SAFB2 UBA6 HERC2 TACC3 CABIN1 CAMSAP2 WNK3 CNP	5.37e-08	963	153	19	28671696
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	TPR ASXL1 CENPE COG7 SYNE1 SIPA1L3 PABPC4 APOA1 DCAF16 PABPC1 NEK9 KIF24 STOX2 ANAPC1 P4HB ASPM SF3A3 HERC2 TACC3 NXF1	1.91e-07	1155	153	20	20360068
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	PRUNE2 SMG1 ZHX3 ASXL1 SYNE1 DOCK9 SIPA1L3 HIC2 TTC7A	7.52e-07	225	153	9	12168954
Pubmed	A combination of proatherogenic single-nucleotide polymorphisms is associated with increased risk of coronary artery disease and myocardial infarction in Asian Indians.	CETP APOA1 ABCB1	8.29e-07	5	153	3	19558216
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	TPR MYH13 CENPE SYNE1 FAT3 TEX15 TRIP12 PABPC1 ASPM	1.04e-06	234	153	9	36243803
Pubmed	Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.	CETP APOA1 ABCB1	1.65e-06	6	153	3	20578904
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH4 MYH7 MYH13	2.88e-06	7	153	3	35210422
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SMG1 RELCH ABCA2 FBF1 HIC2 SPG11 CEMIP2 STOX2 NRXN3 MORF4L2 MED12L ATP1A2	4.30e-06	529	153	12	14621295
Pubmed	Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle.	MYH4 MYH7 PPARGC1A	1.34e-05	11	153	3	18310078
Pubmed	Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers.	MYH4 MYH7 PPARGC1A	1.34e-05	11	153	3	16024798
Pubmed	HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis.	ATR HELQ FANCD2	1.78e-05	12	153	3	24005329
Pubmed	In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness.	PROM1 PLCB2	1.92e-05	2	153	2	24330829
Pubmed	RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1α-mediated mitochondrial oxidative phosphorylation and glycolysis.	RIPK1 PPARGC1A	1.92e-05	2	153	2	24583643
Pubmed	Length-dependent effects on cardiac contractile dynamics are different in cardiac muscle containing α- or β-myosin heavy chain.	MYH4 MYH7	1.92e-05	2	153	2	23111184
Pubmed	CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway.	RASA4 RASA4B	1.92e-05	2	153	2	11448776
Pubmed	The competing endogenous RNA network of CYP4Z1 and pseudogene CYP4Z2P exerts an anti-apoptotic function in breast cancer.	CYP4Z1 CYP4Z2P	1.92e-05	2	153	2	28236635
Pubmed	Increased MDR1 Transporter Expression in Human Brain Endothelial Cells Through Enhanced Histone Acetylation and Activation of Aryl Hydrocarbon Receptor Signaling.	ABCB1 AHR	1.92e-05	2	153	2	30963442
Pubmed	Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma.	CYP4Z1 CYP4Z2P	1.92e-05	2	153	2	15059886
Pubmed	Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.	CETP APOA1	1.92e-05	2	153	2	25341944
Pubmed	Redox-regulated peptide transfer from the transporter associated with antigen processing to major histocompatibility complex class I molecules by protein disulfide isomerase.	P4HB NXF1	1.92e-05	2	153	2	21299467
Pubmed	Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.	CETP APOA1	1.92e-05	2	153	2	26966279
Pubmed	Differential interaction of the human cholesteryl ester transfer protein with plasma high density lipoproteins (HDLs) from humans, control mice, and transgenic mice to human HDL apolipoproteins. Lack of lipid transfer inhibitory activity in transgenic mice expressing human apoA-I.	CETP APOA1	1.92e-05	2	153	2	9305883
Pubmed	Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy.	ABCB1 PROM1	1.92e-05	2	153	2	28137267
Pubmed	Senescence-related truncation and multimerization of apolipoprotein A-I in high-density lipoprotein with an elevated level of advanced glycated end products and cholesteryl ester transfer activity.	CETP APOA1	1.92e-05	2	153	2	20421239
Pubmed	Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam Study.	CETP APOA1	1.92e-05	2	153	2	20195290
Pubmed	The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.	CYP4Z1 CYP4Z2P	1.92e-05	2	153	2	25701119
Pubmed	Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.	TEX15 FANCD2	1.92e-05	2	153	2	28386063
Pubmed	Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer.	ABCB1 PROM1	1.92e-05	2	153	2	32203206
Pubmed	Cholesteryl ester transfer protein I405V polymorphism influences apolipoprotein A-I response to a change in dietary fatty acid composition.	CETP APOA1	1.92e-05	2	153	2	19242900
Pubmed	UBA6 Inhibition Accelerates Lysosomal TRPML1 Depletion and Exosomal Secretion in Lung Cancer Cells.	MCOLN1 UBA6	1.92e-05	2	153	2	38474091
Pubmed	Mitotic DNA Synthesis in Untransformed Human Cells Preserves Common Fragile Site Stability via a FANCD2-Driven Mechanism That Requires HELQ.	HELQ FANCD2	1.92e-05	2	153	2	37777152
Pubmed	ATR couples FANCD2 monoubiquitination to the DNA-damage response.	ATR FANCD2	1.92e-05	2	153	2	15314022
Pubmed	The association of common SNPs and haplotypes in the CETP and MDR1 genes with lipids response to fluvastatin in familial hypercholesterolemia.	CETP ABCB1	1.92e-05	2	153	2	16002074
Pubmed	Characterization of HRG22, a human homologue of the putative tumor suppressor gene HIC1.	HIC1 HIC2	1.92e-05	2	153	2	11554746
Pubmed	Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action.	CETP APOA1	1.92e-05	2	153	2	16326978
Pubmed	An essential function for the calcium-promoted Ras inactivator in Fcgamma receptor-mediated phagocytosis.	RASA4 RASA4B	1.92e-05	2	153	2	16041389
Pubmed	Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production.	RIPK1 PABPC4 PABPC1	2.93e-05	14	153	3	28900035
Pubmed	Defective excitation-contraction coupling is partially responsible for impaired contractility in hindlimb muscles of Stac3 knockout mice.	MYH4 MYH7 PPARGC1A	2.93e-05	14	153	3	27184118
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	MMS22L CENPE DOCK9 GPR161 BMP3 DUSP16 ASPM SAFB2 CABIN1	3.55e-05	363	153	9	14691545
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	TPR CPNE8 SYNE1 PABPC4 SEC22B TRIP12 PABPC1 ABCB1 P4HB SF3A3 SAFB2 UBA6 HERC2 NXF1 CNP	4.96e-05	1024	153	15	24711643
Pubmed	PGC-1α4 Interacts with REST to Upregulate Neuronal Genes and Augment Energy Consumption in Developing Cardiomyocytes.	MYH7 PPARGC1A ATP1A2	5.43e-05	17	153	3	36230906
Pubmed	IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism.	MYH4 MYH7 PPARGC1A	5.43e-05	17	153	3	22351927
Pubmed	Calcineurin inhibitor protein (CAIN) attenuates Group I metabotropic glutamate receptor endocytosis and signaling.	GRM1 CABIN1	5.75e-05	3	153	2	19717561
Pubmed	CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane.	RASA4 RASA4B	5.75e-05	3	153	2	25637021
Pubmed	Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment.	MORF4L2 ASPM	5.75e-05	3	153	2	25796627
Pubmed	Nuclear relocalisation of cytoplasmic poly(A)-binding proteins PABP1 and PABP4 in response to UV irradiation reveals mRNA-dependent export of metazoan PABPs.	PABPC4 PABPC1	5.75e-05	3	153	2	21940797
Pubmed	TEX15 associates with MILI and silences transposable elements in male germ cells.	PIWIL4 TEX15	5.75e-05	3	153	2	32381626
Pubmed	Relationship between gene polymorphisms and prevalence of myocardial infarction among diabetic and non-diabetic subjects.	CETP APOA1	5.75e-05	3	153	2	15585206
Pubmed	Remodeling of Interstrand Crosslink Proximal Replisomes Is Dependent on ATR, FANCM, and FANCD2.	ATR FANCD2	5.75e-05	3	153	2	31067464
Pubmed	ABCB1 is predominantly expressed in human fetal neural stem/progenitor cells at an early development stage.	ABCB1 PROM1	5.75e-05	3	153	2	19384922
Pubmed	Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.	ABCB1 PROM1	5.75e-05	3	153	2	22395309
Pubmed	Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans.	FMO3 ABCB1	5.75e-05	3	153	2	16800822
Pubmed	Human DNA helicase HELQ participates in DNA interstrand crosslink tolerance with ATR and RAD51 paralogs.	ATR HELQ	5.75e-05	3	153	2	24005565
Pubmed	Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.	ATR FANCD2	5.75e-05	3	153	2	16943440
Pubmed	Regulation of the Fanconi Anemia DNA Repair Pathway by Phosphorylation and Monoubiquitination.	ATR FANCD2	5.75e-05	3	153	2	34828369
Pubmed	Coordinated regulation of XPA stability by ATR and HERC2 during nucleotide excision repair.	ATR HERC2	5.75e-05	3	153	2	23178497
Pubmed	A novel hierarchical prognostic model of AML solely based on molecular mutations.	ASXL1 PML	5.75e-05	3	153	2	22915647
Pubmed	Expression of multidrug resistance genes in normal and cancer stem cells.	ABCB1 PROM1	5.75e-05	3	153	2	18568776
Pubmed	Differential roles for Chk1 and FANCD2 in ATR-mediated signalling for psoralen photoactivation-induced senescence.	ATR FANCD2	5.75e-05	3	153	2	21995812
Pubmed	A proteomic study of protein variation between osteopenic and age-matched control bone tissue.	APOA1 CA1	5.75e-05	3	153	2	22619369
Pubmed	Sepsis-induced myocardial depression is associated with transcriptional changes in energy metabolism and contractile related genes: a physiological and gene expression-based approach.	MYH7 PPARGC1A	5.75e-05	3	153	2	20101178
Pubmed	Molecular organization and dynamics of the melatonin MT₁ receptor/RGS20/G(i) protein complex reveal asymmetry of receptor dimers for RGS and G(i) coupling.	RGS20 MTNR1A	5.75e-05	3	153	2	20859254
Pubmed	The ATM-related kinase, hSMG-1, bridges genome and RNA surveillance pathways.	SMG1 ATR	5.75e-05	3	153	2	15279777
Pubmed	Apolipoprotein A-I stimulates cholesteryl ester transfer protein and apolipoprotein E secretion from lipid-loaded macrophages; the role of NF-κB and PKA signaling pathways.	CETP APOA1	5.75e-05	3	153	2	22056562
Pubmed	Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.	CYP4Z1 CYP4Z2P	5.75e-05	3	153	2	30832689
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TPR ATR DYNC2H1 SYNE1 PABPC4 SEC22B MSH3 GRM1 PABPC1 NEK9 FANCD2 ANAPC1 P4HB SF3A3 SAFB2 UBA6 ANP32E NXF1	5.89e-05	1425	153	18	30948266
Pubmed	A human MAP kinase interactome.	TPR ANK3 RIPK1 SYNE1 LAMA3 PROM1 DUSP16 WASH2P HERC2 WDR44	6.27e-05	486	153	10	20936779
Pubmed	Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.	SMG1 MMS22L MSH3 MSH4 HELQ FANCD2	7.18e-05	157	153	6	30686591
Pubmed	Tbx15 controls skeletal muscle fibre-type determination and muscle metabolism.	MYH4 MYH7 PPARGC1A	9.01e-05	20	153	3	26299309
Pubmed	Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ABCA2 DOCK9 HIC2 CAMSAP2 DOP1A	9.99e-05	104	153	5	10470851
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	TPR CHD2 SEC22B CHD1L MSH3 TRIP12 PABPC1 NEK9 P4HB SGPL1 ASPM SF3A3 SAFB2 PRR14L HERC2 NXF1 CNP	1.02e-04	1353	153	17	29467282
Pubmed	Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT).	ATR CHD2 MSH3 FANCD2	1.03e-04	55	153	4	27114453
Pubmed	Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.	ANKS1B LAMA3 NRXN3	1.05e-04	21	153	3	22959728
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MYH4 MXRA5 CCDC73 CENPE HIC2 CHD2 TRIP12 DNAH14 DUSP16 AHR ANP32E NXF1	1.08e-04	736	153	12	29676528
Pubmed	ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis.	ATR PML	1.15e-04	4	153	2	16891316
Pubmed	Gene-gene combination effect and interactions among ABCA1, APOA1, SR-B1, and CETP polymorphisms for serum high-density lipoprotein-cholesterol in the Japanese population.	CETP APOA1	1.15e-04	4	153	2	24376512
Pubmed	The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif.	HIC1 HIC2	1.15e-04	4	153	2	12052894
Pubmed	HERC2/USP20 coordinates CHK1 activation by modulating CLASPIN stability.	ATR HERC2	1.15e-04	4	153	2	25326330
Pubmed	Two novel/ancient myosins in mammalian skeletal muscles: MYH14/7b and MYH15 are expressed in extraocular muscles and muscle spindles.	MYH4 MYH7	1.15e-04	4	153	2	19948655
Pubmed	The Tpr protein regulates export of mRNAs with retained introns that traffic through the Nxf1 pathway.	TPR NXF1	1.15e-04	4	153	2	21613532
Pubmed	mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.	ABCA2 ABCB1	1.15e-04	4	153	2	24145140
Pubmed	Identification of an alternatively spliced variant of Ca2+-promoted Ras inactivator as a possible regulator of RANKL shedding.	RASA4 RASA4B	1.15e-04	4	153	2	16234249
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH4 MYH13	1.15e-04	4	153	2	10388558
Pubmed	Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.	CETP APOA1	1.15e-04	4	153	2	19217440
Pubmed	Ca2+-dependent monomer and dimer formation switches CAPRI Protein between Ras GTPase-activating protein (GAP) and RapGAP activities.	RASA4 RASA4B	1.15e-04	4	153	2	21460216
Pubmed	PML regulates p53 stability by sequestering Mdm2 to the nucleolus.	ATR PML	1.15e-04	4	153	2	15195100
Pubmed	The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways.	ATR FANCD2	1.15e-04	4	153	2	14988723
Pubmed	[Influence of genetic combinations on HDL-C levels in a Southern Brazilian population].	CETP APOA1	1.15e-04	4	153	2	20835684
Pubmed	TEX15 is an essential executor of MIWI2-directed transposon DNA methylation and silencing.	PIWIL4 TEX15	1.15e-04	4	153	2	32719317
Pubmed	FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway.	ATR FANCD2	1.15e-04	4	153	2	18931676
Pubmed	Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.	HIC1 ATR CETP WNT9B APOA1 ABCB1 BMPR1B AHR	1.16e-04	331	153	8	20634891
Pubmed	PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.	CENPE NEK9 SGPL1 ASPM MPHOSPH10 HERC2 TACC3	1.18e-04	247	153	7	32989298
Pubmed	Identification of heat shock factor 1 molecular and cellular targets during embryonic and adult female meiosis.	MSH3 MSH4 TEX15	1.21e-04	22	153	3	21690297
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	ASXL1 MMS22L UBE3B FBF1 PABPC4 ANKS1B CDH23 NUTM2D SEC22B REN NEK9 KIF24 ATP8B2 ARSG ASPM ANP32E	1.24e-04	1242	153	16	30973865
Pubmed	A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response.	CETP APOA1 REN	1.79e-04	25	153	3	12544508
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	MXRA5 CCDC73 DYNC2H1 SYNE1 PABPC4 PABPC1	1.87e-04	187	153	6	26460568
Pubmed	hMSH5: a human MutS homologue that forms a novel heterodimer with hMSH4 and is expressed during spermatogenesis.	MSH3 MSH4	1.91e-04	5	153	2	10029069
Pubmed	Glial ankyrins facilitate paranodal axoglial junction assembly.	ANK3 CNP	1.91e-04	5	153	2	25362471
GeneFamily	Myosin heavy chains	MYH4 MYH7 MYH13	8.00e-05	15	104	3	1098
GeneFamily	MutS homologs\|PWWP domain containing	MSH3 MSH4	3.24e-04	5	104	2	1026
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	DOCK9 PLEKHS1 FGD4 GAB3 RASA4B CADPS2	1.22e-03	206	104	6	682
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA4 RASA4B	1.43e-03	10	104	2	830
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	TPR ZHX3 RELCH ANK3 FAT3 MSH3 TRIP12 PPARGC1A FGD4 ASPM HERC2 CAMSAP2	9.68e-06	369	146	12	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000	SMG1 RELCH MYH7 ANK3 CENPE WNT9B APOA1 MSH3 PABPC1 PROM1 PPARGC1A BMPR1B FGD4 ASPM SF3A3 MED12L CADPS2 CAMSAP2	1.02e-05	801	146	18	gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	TPR SMG1 ZHX3 RELCH HIC1 ANK3 FAT3 MSH3 PPARGC1A ANAPC1 CAMSAP2	1.09e-05	312	146	11	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	CENPE VPS45 FAT3 CHD2 PROM1 PPARGC1A BMP3 BMPR1B RGS20 SLC22A8 FGD4 DUSP16 ASPM MED12L MPHOSPH10 DOP1A	1.16e-05	654	146	16	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	SMG1 RELCH MMS22L ATR CCDC73 RUNDC3B CHD1L TEX15 KIF24 FANCD2 SGPL1 MED12L UBA6 WNK3 ZMYM6 WDR44 DOP1A	5.02e-05	820	146	17	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500	ZHX3 RELCH ANK3 FAT3 MSH3 PPARGC1A ASPM HERC2	6.04e-05	194	146	8	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	RELCH ATR CCDC73 RUNDC3B TEX15 ZMYM6	1.13e-04	110	146	6	gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	SMG1 RELCH ANK3 CENPE MSH3 PPARGC1A ASPM SF3A3 MED12L CAMSAP2	1.22e-04	339	146	10	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	TPR SMG1 ZHX3 RELCH MYH7 HIC1 ANK3 FAT3 SIPA1L3 LAMA3 MSH3 PPARGC1A STOX2 ANAPC1 CAMSAP2 HDC	1.40e-04	806	146	16	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500	ABCA2 EFCAB6 CENPE DYNC2H1 FAT3 CEMIP2 PROM1 PPARGC1A NRXN3 SLC22A8 FGD4 ASPM	1.68e-04	496	146	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	TPR ABCA2 GANC CENPE DYNC2H1 FAT3 HIC2 KIF24 CEMIP2 TTC7A PROM1 PPARGC1A TMTC1 STOX2 CFAP54 SLC22A8 FGD4 ASPM ANP32E MPHOSPH10 CADPS2 WNK3	1.71e-04	1370	146	22	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000	CCDC73 COG7 DOCK9 MSH4 TEX15 ABCB1 CCNB3 WDR44	1.96e-04	230	146	8	gudmap_developingGonad_e18.5_ovary_1000_k5
CoexpressionAtlas	NK cells, NK.MCMV1.Sp, CD3-,NK1.1+, Spleen, avg-3	MMS22L CENPE RUNDC3B PRAG1 CEMIP2 ABCB1 ELMO2 NFIL3 GAB3 PML	2.33e-04	367	146	10	GSM538309_500
CoexpressionAtlas	NK cells, NK.H+.MCMV1.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3	HIC1 RUNDC3B PRAG1 ATP8B2 CEMIP2 ABCB1 ELMO2 NFIL3 GAB3 PML	2.48e-04	370	146	10	GSM538300_500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	TPR ABCA2 GANC CENPE FAT3 ANKS1B KIF24 CEMIP2 ABCB1 FANCD2 PROM1 PPARGC1A STOX2 CFAP54 NRXN3 SLC22A8 ASPM ANP32E PLCB2 MPHOSPH10 WNK3 HDC	2.66e-04	1414	146	22	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500	ATR CCDC73 RUNDC3B TEX15 UBA6 WDR44	2.71e-04	129	146	6	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_100	CCDC73 TEX15 CCNB3	2.85e-04	19	146	3	gudmap_developingGonad_e18.5_ovary_100_k1
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000	SMG1 CCDC73 TEX15 SGPL1 UBA6 WDR44 DOP1A	3.18e-04	187	146	7	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500	MMS22L ATR CCDC73 RUNDC3B CHD1L TEX15 FANCD2 UBA6 WNK3 WDR44	3.40e-04	385	146	10	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4	CENPE DYNC2H1 FAT3 PROM1 PPARGC1A ASPM	4.04e-04	139	146	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2	ABCA2 DYNC2H1 CEMIP2 PROM1 PPARGC1A STOX2 NRXN3 FGD4 WNK3 WDR44	4.16e-04	395	146	10	Facebase_RNAseq_e8.5_Floor Plate_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	TPR ABCA2 EFCAB6 CENPE DYNC2H1 FAT3 ABCC9 CEMIP2 PROM1 PPARGC1A BMP3 TMTC1 STOX2 NRXN3 SLC22A8 FGD4 ASPM	4.48e-04	986	146	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
ToppCell	COVID-19-Heart-EC_3\|Heart / Disease (COVID-19 only), tissue and cell type	CPNE8 ZBTB7C RUNDC3B DOCK9 WNT9B CEMIP2 ABCB1 TMTC1 STOX2 CADPS2	1.21e-09	190	153	10	78e7c502b0450c0b37652b1896a2a752fd8a2111
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	PRUNE2 ANK3 ABCB1 PROM1 PPARGC1A STOX2 BMPR1B CADPS2	1.78e-07	176	153	8	36f77d878a53b30465b0dea8333a3865dba75613
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANK3 CCDC73 GPR37L1 TEX15 FANCD2 C11orf91 ATP1A2 CNP	1.86e-07	177	153	8	59cf56c385c324f0844f20003d2b5049a2791e45
ToppCell	COVID-19-Heart-EC_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZBTB7C RUNDC3B DOCK9 WNT9B ABCB1 TMTC1 STOX2 CADPS2	2.40e-07	183	153	8	ff95382cfed592190d0636d2b750328471f82e0d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZBTB7C FAT3 LAMA3 PRAG1 PPARGC1A BMPR1B PRDM8 CADPS2	2.51e-07	184	153	8	6475a43201b136dcc9b113d2ca4cfa154ed9d65d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 DOCK9 LAMA3 DNAH14 BMP3 STOX2 FGD4 CADPS2	3.33e-07	191	153	8	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	ANK3 DYNC2H1 SYNE1 PLEKHS1 CYP4Z2P BMPR1B CFAP54 CADPS2	3.90e-07	195	153	8	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	ANK3 DYNC2H1 SYNE1 PLEKHS1 CYP4Z2P BMPR1B CFAP54 CADPS2	3.90e-07	195	153	8	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	CPNE8 RUNDC3B SYNE1 DOCK9 PRAG1 ABCB1 TMTC1 CADPS2	4.21e-07	197	153	8	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC73 DOCK9 GPR82 CDH23 CEMIP2 GPR161 SAFB2	1.57e-06	163	153	7	7a04192710f55acf5a4681d5f09942358fdb02ff
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC73 GPR82 CDH23 MSH3 CEMIP2 GPR161 SAFB2	1.84e-06	167	153	7	528493896aebe7d03d4b6ad2341b12927859e2e4
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC73 GPR82 CDH23 MSH3 CEMIP2 GPR161 SAFB2	1.84e-06	167	153	7	a82e85caf79395baa48380786d9df32a86dfd1ce
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 MYH4 FAT3 ABCB1 PROM1 STOX2 CFAP54	3.14e-06	181	153	7	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	Myeloid-Myeloid-C_(Cd16+_Monocyte)\|Myeloid / shred on cell class and cell subclass (v4)	OTOA FMO3 REN GPR161 FGD4 DUSP16	3.21e-06	117	153	6	d1936e76a935216783a73ab414e4147fa48e68eb
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	SFTA2 ANK3 SYNE1 ABCC9 CYP4Z2P AHR CADPS2	3.37e-06	183	153	7	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 MMS22L RADX KIF24 BMPR1B ASPM TACC3	3.37e-06	183	153	7	42dc31d587fbb9724b2f0be5ee8ed77233f67b86
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	SFTA2 ANK3 CYP4Z2P BMPR1B AHR CADPS2 CA1	3.76e-06	186	153	7	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	RUNDC3B DOCK9 CEMIP2 ABCB1 TMTC1 STOX2 CADPS2	4.03e-06	188	153	7	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 SYNE1 SIPA1L3 DNAH14 PROM1 STOX2 CFAP54	4.03e-06	188	153	7	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	ANK3 DOCK9 DNAH14 PTP4A3 NRXN3 DUSP16 CADPS2	4.03e-06	188	153	7	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MMS22L CENPE KIF24 FANCD2 ASPM ANP32E TACC3	4.17e-06	189	153	7	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	SFTA2 ANK3 CYP4Z2P PPARGC1A BMPR1B AHR CADPS2	4.47e-06	191	153	7	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 DOCK9 LAMA3 DNAH14 STOX2 FGD4 CADPS2	4.63e-06	192	153	7	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	CPNE8 DOCK9 CEMIP2 TMTC1 BMPR1B NRXN3 CADPS2	4.79e-06	193	153	7	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	ZHX3 DOCK9 CEMIP2 TMTC1 BMPR1B NRXN3 CADPS2	4.79e-06	193	153	7	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	RV-09._Endothelium_I\|RV / Chamber and Cluster_Paper	RUNDC3B SYNE1 DOCK9 PRAG1 ABCB1 TMTC1 CADPS2	4.95e-06	194	153	7	7b408096e717f2327c12aea35a8d5fc4621d3b06
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 ANK3 SIPA1L3 DNAH14 PPARGC1A STOX2 FGD4	4.95e-06	194	153	7	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	SFTA2 ANK3 SYNE1 DOCK9 CYP4Z2P STOX2 CADPS2	5.12e-06	195	153	7	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	ANK3 DYNC2H1 FRMPD2 PLEKHS1 CYP4Z2P BMPR1B CFAP54	5.12e-06	195	153	7	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	RUNDC3B SYNE1 DOCK9 PRAG1 ABCB1 TMTC1 CADPS2	5.12e-06	195	153	7	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	SFTA2 ANK3 SYNE1 DOCK9 CYP4Z2P STOX2 CADPS2	5.12e-06	195	153	7	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	CPNE8 SYNE1 DOCK9 PRAG1 TMTC1 STOX2 CADPS2	5.12e-06	195	153	7	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 SIPA1L3 LAMA3 DNAH14 STOX2 FGD4 CADPS2	5.85e-06	199	153	7	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	CPNE8 RUNDC3B SYNE1 CEMIP2 ABCB1 STOX2 ATP1A2	6.05e-06	200	153	7	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZBTB7C PLEKHS1 PROM1 BMPR1B PRDM8 NRXN3 AHR	6.05e-06	200	153	7	b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	CPNE8 RUNDC3B SYNE1 CEMIP2 ABCB1 STOX2 ATP1A2	6.05e-06	200	153	7	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	CPNE8 RUNDC3B SYNE1 CEMIP2 ABCB1 STOX2 ATP1A2	6.05e-06	200	153	7	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	CPNE8 RUNDC3B SYNE1 CEMIP2 ABCB1 STOX2 ATP1A2	6.05e-06	200	153	7	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	CPNE8 RUNDC3B SYNE1 CEMIP2 ABCB1 STOX2 ATP1A2	6.05e-06	200	153	7	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	CPNE8 RUNDC3B SYNE1 CEMIP2 ABCB1 STOX2 ATP1A2	6.05e-06	200	153	7	7136936d05ab344a560cf159684c881063b5430d
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	GPR82 PTP4A3 DUSP16 RASA4B FAM124B CAMSAP2	1.93e-05	160	153	6	c2b5fadb4bac17fafc08831f6d3f4ff96ada7e70
ToppCell	LPS-antiTNF-Endothelial-Endothelial-FOXM1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MMS22L CENPE KIF24 FANCD2 ASPM TACC3	2.14e-05	163	153	6	5285318c52aa31c9b22dc2ffff078e32e408604d
ToppCell	Control\|World / group, cell type (main and fine annotations)	ANK3 SYNE1 ANKS1B LAMA3 STOX2 NRXN3	2.54e-05	168	153	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA3 TEX15 KIF24 FANCD2 ASPM TACC3	2.63e-05	169	153	6	0bc8ef341ce307b19018d4ac8de0a4d04254209d
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPE KIF24 FGD4 ASPM ANP32E TACC3	2.63e-05	169	153	6	4db49b7eaea34e6558ee73b01e76315e99cc880b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH7 REN TMTC1 PTP4A3 NRXN3 ATP1A2	2.72e-05	170	153	6	99dd734c0972a40d5381e8e2d96bdaa31f6d06e6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH7 REN TMTC1 PTP4A3 NRXN3 ATP1A2	2.72e-05	170	153	6	3a14eeae221b8bb0bd0dadcb8e7a603431240a1e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH7 REN TMTC1 PTP4A3 NRXN3 ATP1A2	2.72e-05	170	153	6	cdb6fad277f284c3fd5a6f45672a8edc24715882
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE8 MYH13 ABCC9 CEMIP2 ABCB1 BMP3	2.90e-05	172	153	6	ddecdb1a0791296929790f78b49008f51a130f8b
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZBTB7C FRMPD2 DNAH14 GPR161 PRDM8 CADPS2	3.00e-05	173	153	6	8335b77f730ed43fc348a005566e73a103c6774b
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCOLN1 CEMIP2 PRUNE1 PROM1 SLC22A8 ASPM	3.09e-05	174	153	6	9d5dcd46cf346c381dea68ada6665f7fb68114a3
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCOLN1 CEMIP2 PRUNE1 PROM1 SLC22A8 ASPM	3.09e-05	174	153	6	53cec5c666c45278a71c21dd9c62a052a97e0fdf
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PRUNE2 PIWIL4 DNAH14 BMPR1B PRDM8 CADPS2	3.09e-05	174	153	6	2947e5906b172d149412fa4e77476fce4ea695d2
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	PLEKHS1 PROM1 BMPR1B PRDM8 NRXN3 CA1	3.09e-05	174	153	6	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE8 ABCC9 TEX15 CEMIP2 ABCB1 BMP3	3.20e-05	175	153	6	90e29945aa861082c94bb4f331161adc3a6ef899
ToppCell	droplet-Lung-LUNG-30m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFTA2 MYH7 FMO3 MYH13 ANK3 RGS20	3.30e-05	176	153	6	5201f003192c033655ba47f0faf8c47a96eae03d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 SYNE1 FAT3 PROM1 STOX2 CFAP54	3.30e-05	176	153	6	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZBTB7C FRMPD2 PRAG1 DNAH14 PRDM8 CADPS2	3.30e-05	176	153	6	40993c41c1017b53039a337174fc56632b278609
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPE SYNE1 CEMIP2 PROM1 ASPM TACC3	3.51e-05	178	153	6	15a99080e9f669572ab6d82934f324e6714846c1
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPE SYNE1 CEMIP2 PROM1 ASPM TACC3	3.51e-05	178	153	6	200308e109abb7e6f8816a6f8cce6d56862d4098
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKS1B GPR37L1 FAM217A PPARGC1A C11orf91 CNP	3.51e-05	178	153	6	ef490b45901b2e6dedb519540fa3ae4e4db3a9ba
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZBTB7C FAT3 GRM1 PRAG1 BMPR1B MED12L	3.51e-05	178	153	6	ccea3c8908d72f5fecd151a133048c8e9758304c
ToppCell	Adult-Epithelial-club_cell-D122\|Adult / Lineage, Cell type, age group and donor	PLEKHS1 PROM1 PPARGC1A BMPR1B AHR CA1	3.51e-05	178	153	6	35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17
ToppCell	wk_08-11-Epithelial-PNS-Proliferating_Schwann\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GPR37L1 APOA1 NRXN3 AHR ATP1A2 CNP	3.63e-05	179	153	6	ab23fee9adab1e63d5b5cd9faba6b9a92beef425
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	SYNE1 ATP8B2 TLR8 TMTC1 GAB3 FAM124B	3.63e-05	179	153	6	cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 BMP3 STOX2 BMPR1B NRXN3 CADPS2	3.63e-05	179	153	6	815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCell	droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SFTA2 MYH7 ANK3 SIPA1L3 PGBD1 P2RX5	3.63e-05	179	153	6	ca70a5518c5a5392e088c103e0cb44aa084f5332
ToppCell	droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SFTA2 MYH7 ANK3 SIPA1L3 PGBD1 P2RX5	3.63e-05	179	153	6	c451b074b04eb5d6c575c6abaedda579c6744bbf
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PRUNE2 ZBTB7C RUNDC3B CEMIP2 BMPR1B NRXN3	3.63e-05	179	153	6	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZBTB7C PRAG1 BMPR1B PRDM8 MED12L CADPS2	3.74e-05	180	153	6	5e78b29fa1cbdcf502fee3577e5b45766b90d1dc
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CENPE KIF24 FANCD2 ASPM MED12L TACC3	3.74e-05	180	153	6	401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE8 ABCC9 CEMIP2 ABCB1 BMP3 CADPS2	3.74e-05	180	153	6	b514c55e52b46e8a1a2f09ed2c59a7683367a505
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZBTB7C FAT3 LAMA3 PRAG1 PRDM8 CADPS2	3.74e-05	180	153	6	5391d23817f5cc88a0871ddb98968897c839f464
ToppCell	LPS-IL1RA-Endothelial-Endothelial-FOXM1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MMS22L CENPE KIF24 FANCD2 ASPM TACC3	3.74e-05	180	153	6	334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 MYH4 ABCB1 PROM1 STOX2 CFAP54	3.98e-05	182	153	6	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SFTA2 ANK3 LAMA3 BMP3 NRXN3 CADPS2	3.98e-05	182	153	6	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SFTA2 ANK3 LAMA3 BMP3 NRXN3 CADPS2	4.10e-05	183	153	6	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SFTA2 ANK3 LAMA3 BMP3 NRXN3 CADPS2	4.36e-05	185	153	6	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	IPF-Epithelial-ATII\|IPF / Disease state, Lineage and Cell class	SFTA2 ANK3 ABCC9 CYP4Z2P AHR CADPS2	4.36e-05	185	153	6	563b4e6d92bb5d77a3829556116a8e99aebac615
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 CENPE RADX BMPR1B ASPM TACC3	4.36e-05	185	153	6	57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	ANK3 DOCK9 STOX2 BMPR1B NRXN3 CADPS2	4.36e-05	185	153	6	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	CENPE KIF24 FANCD2 P2RX5 ASPM TACC3	4.36e-05	185	153	6	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CENPE LAMA3 KIF24 FANCD2 ASPM TACC3	4.36e-05	185	153	6	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZBTB7C LAMA3 PRAG1 BMPR1B PRDM8 CADPS2	4.36e-05	185	153	6	10da5c2a92bfb3248d3f6f94a0933996326cf590
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes\|lymph-node_spleen / Manually curated celltypes from each tissue	ZBTB7C CDH23 MCOLN1 TMTC1 FGD4 C11orf91	4.49e-05	186	153	6	d7da5edb2ee36f96cdd7e27eb9afcc1cbfd52bb6
ToppCell	droplet-Limb_Muscle-nan-24m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 GPR37L1 TEX15 C11orf91 ATP1A2 CNP	4.49e-05	186	153	6	adba5647a2feaba8e361dc1020d2f2dc4ce36b16
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	SFTA2 ANK3 ABCC9 CYP4Z2P AHR CADPS2	4.49e-05	186	153	6	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 DNAH14 BMP3 STOX2 BMPR1B CADPS2	4.49e-05	186	153	6	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPNE8 DOCK9 APOA1 TMTC1 FGD4 FAM124B	4.49e-05	186	153	6	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	(8)_CD34_progenitor\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	REN PROM1 MED12L FAM124B CA1 HDC	4.49e-05	186	153	6	943c604a7cd873faf510096d094100512ba2d6bc
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 DOCK9 DNAH14 PTP4A3 AHR CADPS2	4.49e-05	186	153	6	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	(8)_CD34_progenitor\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	REN PROM1 MED12L FAM124B CA1 HDC	4.49e-05	186	153	6	e69a986b8618effd61875fda528a2e44aab11868
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 ZHX3 SYNE1 DNAH14 STOX2 CFAP54	4.49e-05	186	153	6	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	DOCK9 WNT9B CEMIP2 ABCB1 TMTC1 CADPS2	4.63e-05	187	153	6	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HIC1 FMO3 ANKS1B ABCC9 PTP4A3 ATP1A2	4.63e-05	187	153	6	150023e6a50c9da461f2321074d2d5e96caafb06
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB7C ABCC9 TMTC1 PTP4A3 NRXN3 ATP1A2	4.63e-05	187	153	6	ec4b694487cc446999c7b27b119950a4f252c4b3
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 ZHX3 EFCAB6 DNAH14 STOX2 CFAP54	4.63e-05	187	153	6	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CENPE LAMA3 KIF24 FANCD2 ASPM TACC3	4.63e-05	187	153	6	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB7C ABCC9 TMTC1 PTP4A3 NRXN3 ATP1A2	4.63e-05	187	153	6	530e4e6d91b5c0d9aa4543caa2b734a1674c5788
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 ANK3 SYNE1 FAT3 PROM1 ATP1A2	4.77e-05	188	153	6	3177b2c1723268d330d3e9f24f9e24492ace6286
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH4 MYH7 MYH13	1.36e-05	10	145	3	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH4 MYH7 MYH13	1.36e-05	10	145	3	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH4 MYH7 MYH13	1.36e-05	10	145	3	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH4 MYH7 MYH13	1.36e-05	10	145	3	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH4 MYH7 MYH13	1.36e-05	10	145	3	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH4 MYH7 MYH13	1.36e-05	10	145	3	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH4 MYH7 MYH13	1.36e-05	10	145	3	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH4 MYH7 MYH13	1.36e-05	10	145	3	DOID:0080326 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH4 MYH7 MYH13	2.48e-05	12	145	3	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH4 MYH7 MYH13	2.48e-05	12	145	3	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH4 MYH7 MYH13	3.21e-05	13	145	3	DOID:397 (implicated_via_orthology)
Disease	Pneumoconiosis	ATR CDH23 CA1	4.07e-05	14	145	3	C0032273
Disease	Bagassosis	ATR CDH23 CA1	4.07e-05	14	145	3	C0004681
Disease	distal arthrogryposis (implicated_via_orthology)	MYH4 MYH7 MYH13	5.06e-05	15	145	3	DOID:0050646 (implicated_via_orthology)
Disease	myopathy (implicated_via_orthology)	MYH4 MYH7 MYH13 CLCNKA	9.20e-05	48	145	4	DOID:423 (implicated_via_orthology)
Disease	Infantile Obesity	CETP APOA1	1.43e-04	4	145	2	C4553478
Disease	bipolar disorder, cytomegalovirus seropositivity	ARSG NFIL3	1.43e-04	4	145	2	EFO_0007037, MONDO_0004985
Disease	Childhood Overweight	CETP APOA1	1.43e-04	4	145	2	C4521075
Disease	Gilles de la Tourette syndrome	CHD2 HDC	1.43e-04	4	145	2	C0040517
Disease	Pediatric Obesity	CETP APOA1	1.43e-04	4	145	2	C2362324
Disease	Adolescent Overweight	CETP APOA1	1.43e-04	4	145	2	C4704956
Disease	Infant Overweight	CETP APOA1	1.43e-04	4	145	2	C4704955
Disease	Adolescent Obesity	CETP APOA1	1.43e-04	4	145	2	C4317171
Disease	Hypertensive disease	CETP APOA1 REN CLCNKA AHR ATP1A2	3.65e-04	190	145	6	C0020538
Disease	Malignant Neoplasms	ATR PLEKHS1 MSH3 ABCB1 AHR	4.36e-04	128	145	5	C0006826
Disease	10-undecenoate 11:1n1 measurement	CYP4Z1 CYP4Z2P	4.96e-04	7	145	2	EFO_0021099
Disease	electrodermal activity measurement, skin conductance response amplitude	ANKS1B NRXN3	4.96e-04	7	145	2	EFO_0006866, EFO_0006868
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	MYH7 SYNE1	4.96e-04	7	145	2	C0751337
Disease	Corneal astigmatism	DOCK9 PPARGC1A BMP3 HERC2	5.73e-04	77	145	4	EFO_1002040
Disease	beta-secretase 1 measurement	CDH23 RGS20	6.59e-04	8	145	2	EFO_0009179
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH4 MYH7 MYH13 PPARGC1A	6.62e-04	80	145	4	DOID:12930 (implicated_via_orthology)
Disease	coronary artery disease	ZHX3 DYNC2H1 CETP DOCK9 UBE3B FBF1 WNT9B CHD2 NEK9 BMPR1B PRDM8 SF3A3 PLCB2 MPHOSPH10 CABIN1	8.19e-04	1194	145	15	EFO_0001645
Disease	Autism Spectrum Disorders	CHD2 TRIP12 NRXN3 MTNR1A	8.32e-04	85	145	4	C1510586
Disease	egg allergy measurement	COG7 BMPR1B	8.44e-04	9	145	2	EFO_0007018
Disease	left ventricular ejection fraction measurement	PRAG1 PROM1 CLCNKA	1.01e-03	40	145	3	EFO_0008373
Disease	age at menarche, spine bone mineral density	RUNDC3B ABCB1	1.05e-03	10	145	2	EFO_0004703, EFO_0007701
Disease	interleukin 17 measurement	ANKS1B GRM1 TTC7A	1.42e-03	45	145	3	EFO_0008174
Disease	triacylglycerol 58:12 measurement	TRIP12 NRXN3	1.53e-03	12	145	2	EFO_0010439
Disease	attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia	SFTA2 ANK3 SYNE1 ANKS1B	1.58e-03	101	145	4	EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Disease	sodium measurement	MMS22L ARSG NRXN3 AHR	1.70e-03	103	145	4	EFO_0009282
Disease	amyotrophic lateral sclerosis, age at onset	ANKS1B NRXN3	2.41e-03	15	145	2	EFO_0004847, MONDO_0004976
Disease	Autosomal recessive primary microcephaly	CENPE ASPM	2.41e-03	15	145	2	cv:C3711387
Disease	lysophosphatidylethanolamine 18:0 measurement	KBTBD3 TMTC1	2.41e-03	15	145	2	EFO_0010367
Disease	response to olanzapine	ANKS1B ATP1A2	2.41e-03	15	145	2	GO_0097333
Disease	Drug habituation	SYNE1 CHD1L NRXN3 CADPS2	2.54e-03	115	145	4	C0013170
Disease	Drug abuse	SYNE1 CHD1L NRXN3 CADPS2	2.54e-03	115	145	4	C0013146
Disease	Prescription Drug Abuse	SYNE1 CHD1L NRXN3 CADPS2	2.54e-03	115	145	4	C4316881
Disease	Substance-Related Disorders	SYNE1 CHD1L NRXN3 CADPS2	2.54e-03	115	145	4	C0236969
Disease	Drug Use Disorders	SYNE1 CHD1L NRXN3 CADPS2	2.54e-03	115	145	4	C0013222
Disease	Drug Dependence	SYNE1 CHD1L NRXN3 CADPS2	2.54e-03	115	145	4	C1510472
Disease	Substance Dependence	SYNE1 CHD1L NRXN3 CADPS2	2.54e-03	115	145	4	C0038580
Disease	Substance Use Disorders	SYNE1 CHD1L NRXN3 CADPS2	2.54e-03	115	145	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	SYNE1 CHD1L NRXN3 CADPS2	2.54e-03	115	145	4	C0029231
Disease	Substance abuse problem	SYNE1 CHD1L NRXN3 CADPS2	2.62e-03	116	145	4	C0740858
Disease	Polyposis, Adenomatous Intestinal	FMO3 MSH3	2.75e-03	16	145	2	C2713442
Disease	Familial Intestinal Polyposis	FMO3 MSH3	2.75e-03	16	145	2	C2713443
Disease	Adenomatous Polyposis Coli	FMO3 MSH3	3.11e-03	17	145	2	C0032580
Disease	Familial Progressive Myoclonic Epilepsy	CHD2 PRDM8	3.11e-03	17	145	2	C0751777
Disease	Atypical Inclusion-Body Disease	CHD2 PRDM8	3.11e-03	17	145	2	C0751776
Disease	Myoclonic Epilepsies, Progressive	CHD2 PRDM8	3.11e-03	17	145	2	C0751778
Disease	Biotin-Responsive Encephalopathy	CHD2 PRDM8	3.11e-03	17	145	2	C0751780
Disease	May-White Syndrome	CHD2 PRDM8	3.11e-03	17	145	2	C0751782
Disease	Dentatorubral-Pallidoluysian Atrophy	CHD2 PRDM8	3.11e-03	17	145	2	C0751781
Disease	Action Myoclonus-Renal Failure Syndrome	CHD2 PRDM8	3.48e-03	18	145	2	C0751779
Disease	Adenocarcinoma of lung (disorder)	ATR PABPC4 APOA1 MSH3 AHR	3.58e-03	206	145	5	C0152013
Disease	Hydrops Fetalis	SGPL1 ATP1A2	3.88e-03	19	145	2	C0020305
Disease	Chronic myeloproliferative disorder	ATR CENPE	3.88e-03	19	145	2	C1292778
Disease	diet measurement, HOMA-B	FAT3 DUSP16	3.88e-03	19	145	2	EFO_0004469, EFO_0008111
Disease	unipolar depression, response to bupropion, mood disorder	ZHX3 STOX2	3.88e-03	19	145	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	Drug-Induced Liver Disease	FMO3 APOA1 ABCB1 SLC22A8 P4HB AHR CADPS2	3.94e-03	404	145	7	C0860207
Disease	Drug-Induced Acute Liver Injury	FMO3 APOA1 ABCB1 SLC22A8 P4HB AHR CADPS2	3.94e-03	404	145	7	C3658290
Disease	Hepatitis, Toxic	FMO3 APOA1 ABCB1 SLC22A8 P4HB AHR CADPS2	3.94e-03	404	145	7	C0019193
Disease	Chemically-Induced Liver Toxicity	FMO3 APOA1 ABCB1 SLC22A8 P4HB AHR CADPS2	3.94e-03	404	145	7	C4279912
Disease	Chemical and Drug Induced Liver Injury	FMO3 APOA1 ABCB1 SLC22A8 P4HB AHR CADPS2	3.94e-03	404	145	7	C4277682
Disease	Hepatitis, Drug-Induced	FMO3 APOA1 ABCB1 SLC22A8 P4HB AHR CADPS2	3.94e-03	404	145	7	C1262760
Disease	Schizophrenia	ANK3 PGBD1 GRM1 ABCB1 PPARGC1A NRXN3 MTNR1A CADPS2 WNK3 CNP PML	4.34e-03	883	145	11	C0036341
Disease	Benign Neoplasm	PLEKHS1 ABCB1 AHR	4.61e-03	68	145	3	C0086692
Disease	Neoplasms	PLEKHS1 ABCB1 AHR	4.61e-03	68	145	3	C0027651
Disease	Infiltrating duct carcinoma of female breast	SMG1 ATR	4.74e-03	21	145	2	C3165106

Protein segments in the cluster

Peptide	Gene	Start	Entry
YLRAKSFFDVALKSS	AHR	76	P35869
STLDSYLKAVFNLSK	CYP4Z2P	206	Q8N1L4
SLKFSSLKYTAKEIT	CHRND	166	Q07001
KGLYIFNLTSLTKSE	BMP3	111	P12645
SFYNLTKLKDEITLS	CFAP54	2251	Q96N23
TTVQASYSKKKLFLS	CETP	386	P11597
LLSALKSLFAKYVSD	COG7	421	P83436
KSLFAKYVSDFTSTL	COG7	426	P83436
RKIAALYDSFTSKSL	ABHD12B	46	Q7Z5M8
LSSLAQKYAEKATQF	ARSG	216	Q96EG1
TLYAFSAIKAILKTN	DOP1A	1381	Q5JWR5
YFIATKLAEAQKSTL	ABCC9	471	O60706
TYLNLSGNKIKDLST	ANP32E	91	Q9BTT0
VSFLSALEEYTKKLN	APOA1	251	P02647
SLYDYLKSTTLDAKS	BMPR1B	286	O00238
NAYTSTQAKALFKID	CDH23	1351	Q9H251
SSSFTLKNYYKILSL	FAM200A	481	Q8TCP9
YTDFQKAVNKLLTAS	DCAF16	201	Q9NXF7
FLKTKAAVISLQSAY	ASPM	1871	Q8IZT6
YGKLSKLQLSSTSFN	ASXL1	1441	Q8IXJ9
QLNKLLTFSSYDSLK	CCNB3	1341	Q8WWL7
TYQDKLSSSKLTSVL	ATP8B2	751	P98198
SSSFKKLYFSLTTEA	RASA4	586	O43374
KLYFSLTTEALSFAK	RASA4	591	O43374
SSSFKKLYFSLTTEA	RASA4B	586	C9J798
KLYFSLTTEALSFAK	RASA4B	591	C9J798
KSSLKLLSTLFANYA	MYH7	611	P12883
LDKSIDNKALYDTFS	PABPC1	106	P11940
TNLSSKAVKAFLDYA	KBTBD3	96	Q8NAB2
LLESSSSYKNLTLKF	MCOLN1	211	Q9GZU1
LSSFTDKELLAYAKA	ABCB1	236	P08183
FSKYSSSIKVESLLT	RADX	516	Q6NSI4
SKSQALAVYKAFTVD	ANAPC1	106	Q9H1A4
LSKSVSKSDSDLIAY	ANKS1B	731	Q7Z6G8
NLSAVFKDLYDKTSA	OTOA	211	Q7RTW8
FLLKNNYKLTSITFS	RELCH	266	Q9P260
STVSALALAFYLAKT	PRUNE1	31	Q86TP1
SSFLFSYLSVQTKKK	HDC	566	P19113
FSRKLTALYTKSTLI	MSH3	326	P20585
LDKSIDNKALYDTFS	PABPC4	106	Q13310
RASIYKSVFSNSSKE	FMO3	51	P31513
FKKTLYNLFTKSNSA	GPR82	316	Q96P67
KSLEIKFQNYSSASE	LINS1	391	Q8NG48
AYFSSILAEKLKLNT	MED12L	71	Q86YW9
KEINSLQSDFTKYLT	LAMA3	2071	Q16787
TSFTLAKQLSFYKIR	NEK9	586	Q8TD19
HKNVLAASSAYLKSL	HIC1	61	Q14526
TESQTYKKRADFLSN	HERC2	2546	O95714
KSSSSYTIFLCILAK	MMS22L	476	Q6ZRQ5
TKKFSLDYLALDFNS	GAB3	526	Q8WWW8
ASTASALKAVNYKIL	NXF1	166	Q9UBU9
NSYTFALFTILKKKS	OR5H2	221	Q8NGV7
SLKLKFGLISSTAYA	NFIL3	121	Q16649
SSLSNYSDLKKESAV	FGD4	31	Q96M96
AFTYCAKTSILSLEK	GANC	886	Q8TET4
KTKSSYLSLATLQAY	NRXN3	876	Q9Y4C0
LSDFSANEQKSTYLK	KIF24	121	Q5T7B8
KYLAKNSASLFTASD	MORF4L2	261	Q15014
ASKFTSLTKVLYDFN	MPHOSPH10	36	O00566
ITSNSDVFSKYQLDK	P4HB	186	P07237
PFSLTSSLKNYFTLK	PCDHGC3	396	Q9UN70
SSLKNYFTLKTSADL	PCDHGC3	401	Q9UN70
ELSNFAYLLASKLSL	NUTM1	1016	Q86Y26
TKSKYDSLDFDSLLK	PPARGC1A	776	Q9UBK2
ASSALIQESLKESYK	DYNC2H1	3466	Q8NCM8
FDNLKKSIAYTLTSN	ATP1A2	766	P50993
SLDFYTKVLKSCRSL	ATR	536	Q13535
FFLETLKKGSYNLTS	FBF1	1116	Q8TES7
LYASKSFALQLSLKQ	FAM124B	176	Q9H5Z6
NYATNLKDKSSLVSS	FAM126A	26	Q9BYI3
YKTSTVSADLANLLK	CABIN1	996	Q9Y6J0
PSADFLTSNKLLKYS	DOCK9	946	Q9BZ29
SLDQFKSKLRSLSYS	ELMO2	491	Q96JJ3
LSSKISYNDFLRAFL	EFCAB6	1486	Q5THR3
DSLLYKTLIDFKSNH	CHD2	626	O14647
SAKYSSLAEAASKAD	CA1	126	P00915
FVTDSAKTSKYLLDL	FRMPD2	616	Q68DX3
SDNKLKTEVSSSIYF	GPR37L1	451	O60883
LKRSFSLDIKSVSYS	DUSP16	396	Q9BY84
SYAAFSANSKLLLKN	CCDC73	711	Q6ZRK6
TTYEICLKDASFLKS	CHD1L	151	Q86WJ1
YDVLTFALKSEQKSL	FAT3	3581	Q8TDW7
FLVSVLYSKAKLASA	ABCA2	801	Q9BZC7
IGSSSLTNLKYKFED	ANK3	2041	Q12955
SDDSYKTLKLLSQHS	ANK3	2431	Q12955
SSILSFTVKAAAKYV	CADPS2	1151	Q86UW7
FDSSTGLLFLYLKAK	CEMIP2	1121	Q9UHN6
KSYSKAFTLTISALF	CNP	276	P09543
DTFKNSKAVYSLIST	DNAH14	2916	Q0VDD8
TLYKKSYLLTLSNKF	GPR161	51	Q8N6U8
TFSRLLNYKYSDTLK	HELQ	546	Q8TDG4
TNDTLLSYFKKVDLN	FAM217A	211	Q8IXS0
SATSIDLSDKTLYKY	GRM1	186	Q13255
SLAKAKYTASDLFRI	SLC22A8	306	Q8TCC7
LDSKANNLSSLSKKY	SEC22B	166	O75396
YTKSIEKLNSSLHFL	CAMSAP2	891	Q08AD1
KLFKNYQTLKTSLAS	CENPE	2341	Q02224
KKKYTNSGTVTLLSF	CPNE8	276	Q86YQ8
VKNKSAFSLNSYKLL	FPGT	561	O14772
KLFYVLSTLAFSKQN	FANCD2	531	Q9BXW9
ILSKSFYTKDCNSLV	PRR14L	531	Q5THK1
YSFSRLDNKLSKSVS	P2RX5	276	Q93086
LSYTDKLCSQKDFVT	NUTM2D	491	Q5VT03
KNVLAASSIYFKSLV	HIC2	61	Q96JB3
YKSLTSLKSNDYLAS	RUNDC3B	446	Q96NL0
KSNLTLYLDESKTLY	TAS2R42	161	Q7RTR8
TSSFKESALRKQSLY	TACC3	546	Q9Y6A5
ISSKFSSKIKYVNSL	PRUNE2	3016	Q8WUY3
TSLYQLQFKEKASSL	SPATA22	226	Q8NHS9
SFYSKLLQLKESLFS	SYNE1	1711	Q8NF91
SAVYKDLLQSLSEKS	RGS20	371	O76081
VFQESYSSKKLCTLA	REN	351	P00797
ASSFKLKNLAQTYLA	PML	721	P29590
LYDSIAFIALKSTDK	PRDM8	51	Q9NQV8
SLNLKADFNYIKSLS	SMG1	1221	Q96Q15
LAQYNTTKDKAFTDL	PROM1	216	O43490
IALLYSHSELSNKAK	PIWIL4	141	Q7Z3Z4
FTKYAAQLDVKTDST	SIPA1L3	666	O60292
KAAYLTSLNSADLLK	MYH4	386	Q9Y623
SKVKNSYSFTSADLI	MSH4	561	O15457
FDSFFTSVKLLSALK	PGBD1	626	Q96JS3
KYQAIFDNTTSLTDK	RIPK1	571	Q13546
LSSSAVLEKLKEYSS	SGPL1	121	O95470
LTISALQLEDSAKYF	TRDV1	96	A0A1B0GX56
FLSFIKTNRYSSKLL	CLCNKA	306	P51800
FDSQSYTFLKALKDE	C11orf91	161	Q3C1V1
STLDSYLKAVFNLSK	CYP4Z1	206	Q86W10
FSFSKLAALNTSKYL	SPG11	1841	Q96JI7
FILSKAGEKSFSLSY	PLEKHS1	41	Q5SXH7
KSYTAADATLKINSQ	UBA6	521	A0AVT1
IYTLTDKYNLESKSL	TLR8	596	Q9NR97
SSYKDSLLLANSKKT	USPL1	111	Q5W0Q7
TNATLSTFIEDLKKY	PTP4A3	26	O75365
VYDLFSLSNKQDKSS	TMTC1	231	Q8IUR5
KASLTYSQLSKEIAN	ERVFRD-1	376	P60508
KQLSKDSILSLYGSQ	SMAP2	261	Q8WU79
NTKISTQLDFASKRY	TPR	711	P12270
LSVNSYHKSSLSLLK	STOX2	711	Q9P2F5
SSLLLFNTTENLYKK	WASH2P	171	Q6VEQ5
SSLLLFNTTENLYKK	WASHC1	171	A8K0Z3
SKNYFLLSSSMDKTV	WDR44	616	Q5JSH3
YQKSSLKLLSFLFSN	MYH13	611	Q9UKX3
IYFSNVISKSDVKSL	VPS45	96	Q9NRW7
STTRATDLKNLFSKY	SAFB2	416	Q14151
LLSNISSKEGTYAKL	PRAG1	941	Q86YV5
FTELKAYDLLSKASV	PLCB2	576	Q00722
SLDSEFYKNLTSIKR	UBE3B	821	Q7Z3V4
SKYFKKLFTAGTLAS	ZBTB7C	56	A1YPR0
KSLVKASYLIAFQTA	ZMYM6	826	O95789
TYSLQATDATLKSKQ	TTC7A	496	Q9ULT0
LQLKLKESFLTNSSY	SFTA2	26	Q6UW10
NLKASEKLDYITYLS	SF3A3	151	Q12874
IDTAFLSSTSKYEKL	TEX15	1191	Q9BXT5
LKYSTKFLSNFLGSK	WNT9B	166	O14905
SGFVKQLLLYLTSKS	TRIP12	1161	Q14669
ITSQAFLDASIYKNK	ZHX3	486	Q9H4I2
KTSFSYEKLQALQET	WNK3	1391	Q9BYP7
HSLKYDKLYSSKNSL	MTNR1A	131	P48039
DLSSLQVFKFSYNKL	MXRA5	101	Q9NR99